Cathy Koger, DO
Dermatology · Boulder, CONPI 1902194871
Payments from drug & device makers
Across 706 payments — averaging $258.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$162K
- UCB, Inc.$9K
- Bristol Myers Squibb$3K
- AbbVie$2K
- Sun Pharmaceutical Industries Inc.$782
- Amgen$705
- plus $5K from 29 others
What the payments were for
- Consulting fees$10,4906%
- Speaking & faculty fees$151,51083%
- Travel & lodging$8,2435%
- Food & beverage$11,7776%
- Education$3250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 252 | $161,661 |
| UCB, Inc. | 14 | $9,315 |
| Bristol Myers Squibb | 3 | $2,975 |
| AbbVie(2 entities) | 98 | $1,648 |
| Sun Pharmaceutical Industries Inc. | 48 | $782 |
| Amgen | 40 | $705 |
| Pfizer | 33 | $556 |
| Sanofi | 20 | $549 |
| Novartis | 25 | $494 |
| E.r. Squibb & Sons, L.L.C. | 17 | $475 |
| Johnson & Johnson | 16 | $462 |
| Galderma Laboratories, L.p. | 32 | $442 |
| Regeneron Healthcare Solutions, Inc. | 16 | $442 |
| LEO Pharma Inc. | 13 | $268 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $244 |
| Almirall LLC | 10 | $208 |
| VYNE Pharmaceuticals Inc. | 4 | $188 |
| Biofrontera Inc. | 8 | $163 |
| Incyte Corporation | 6 | $108 |
| Organon | 8 | $99 |
| Dermavant Sciences, Inc. | 5 | $84 |
| Dermira, Inc. | 4 | $74 |
| Arcutis Biotherapeutics, Inc. | 3 | $53 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $50 |
| Botanix SB Inc | 2 | $44 |
| Genentech USA, Inc. | 2 | $39 |
| Aclaris Therapeutics, Inc. | 2 | $39 |
| Boehringer Ingelheim | 2 | $37 |
| Mission Pharmacal Company | 2 | $30 |
| Journey Medical Corporation | 1 | $28 |
| DUSA Pharmaceuticals, Inc. | 1 | $23 |
| Qiagen, LLC | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$182,345 in reported general payments places this provider in the 95th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 26 | $2,671 |
| Clobetasol Propionate | 38 | $1,450 |
| Doxycycline Hyclate | 48 | $1,293 |
| Ketoconazole | 64 | $861 |
| ValacyclovirValacyclovir Hcl | 16 | $617 |
| Triamcinolone Acetonide | 44 | $614 |
| Ciclopirox | 14 | $365 |
| Mupirocin | 47 | $336 |
| Fluocinonide | 13 | $325 |
| Minoxidil | 16 | $273 |
| Acyclovir | 28 | $193 |
| Hydrocortisone | 15 | $136 |
| Prednisone | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Boulder
- Marcjonathan SerotaLittleton$3.2M
- Stanca BirleaAurora$1.9M
- James SwinehartDenver$931K
- Theodore AlkousakisAurora$880K
- Ammon LarsenLoveland$620K
- Victoria MossColorado Springs$473K
- James JensenCastle Rock$380K
- Cory DunnickAurora$366K
- Kimberly NeymanWheat Ridge$273K
- Sheila BoyleWestminster$240K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.